Updated Publications List


"Astrocytin and malignin: Two Polypeptide Fragments (Recognins) Related to Brain Tumor"; National Cancer Institute Mon. 46:133-137, 1977.

"Disarmed Anti-Malignin Antibodies"; The Lancet 1:987, 1979.

"Monoclonal Anti-Malignin Antibodies"; The Lancet 2:141-142, 1981.

"Determination of Anti-Malignin Antibody and Malignin in 1,026 Cancer Patients and Controls: Relation of Antibody to Survival"; J. Medicine 13:49-69, 1982.

"Anti-Malignin Antibody and Scantag"; Protides Biol. Fluids 30:337-352, 1983.

"Elevated Levels of Anti-Malignin Antibody are Quantitatively Related to Longer Survival in Cancer Patients"; Protides Biol. Fluids 31:739-747, 1984.

"In Vitro Production of the General Transformation Antibody Related to Survival in Human Cancer Patients: Anti-Malignin Antibody (AMA)"; Cancer Detection and Prevention 18:Number 5/6, 551, 1985.

"Increased Accuracy of Anti-Malignin Antibody Determination in Unstored Sera Permits Screening"; Cancer Detection and Prevention 11:Number 1/2, 85, 1987.

"In Vitro Production of the General Transformation Antibody Related to Survival in Human Cancer Patients: Antimalignin Antibody"; Cancer Detection and Prevention 12:313-320,1988.

"Malignin antibody and early malignancy"(abstract below); The Lancet 337:977,1991.

"Malignin Antibody Returns to Normal After Successful Treatment of Breast Cancer"; Cancer Detection and Prevention 17(l):180,1993.

"Malignin Antibody As Early Warning"; Cancer Detection and Prevention 17(l): 229,1993.

"Comparison of Antimalignin With Other Markers for Early Detection and Surrogate Endpoint Use in Chemoprevention Trials for Breast, Colon, and Prostate Cancer"' J. Cell Biochem. 19:61,1994 (National Cancer Institute Symposium).

"Early Detection and Monitoring of Cancer with the Anti-Malignin Antibody Test" ; Cancer Detection and Prevention: 18(l):65-78,1994.

"A Checklist for Suitability of Biomarkers as Surrogate Endpoints in Chemoprevention of Breast Cancer" (abstract below) ; J. Cell. Biochem 19:172-185,1994 (National Cancer Institute Symposium).

"Aglyco Pathology of Viral Receptors in Dementias. In Functional Diversity of Interacting Receptors"; New York Academy of Sciences 757:413-417,1995.

"Return of Elevated Antimalignin Antibody to Normal Indicates Remission of Breast Cancer"; American Association for Cancer Research 37:486,1996.

"Antimalignin Antibody (AMASŪ) Elevation Detects Persistent or Recurrent Breast Cancer"; Cancer Detection and Prevention 20(5):508-509,1996.

"A New Era for Cancer Diagnosis and Treatment Based Upon Earlier, Asymptomatic, Detection"; J. Adv. Med. 10:149-150,1997.

"Production of a Synthetic General Cancer Vaccine Which Augments the Concentration of Antimalignin Antibody In Vivo" ; Cancer Detection and Prevention 22(l):S-227,1998.

"A Quantitative Immune Response in Human Cancer" ; Cancer Detection and Prevention 22(l):S-159,1998.

Source: www.oncolabinc.com Posted 10/06 after Ann Fonfa met S. Winston Bogoch, MD, Chief Operating Officer of Oncolab, Inc. at ASCO (meeting of the American Society for Clinical Oncology), 2006.

Remember we are NOT Doctors and have NO medical training.

This site is like an Encyclopedia - there are many pages, many links on many topics.

Support our work with any size DONATION - see left side of any page - for how to donate. You can help raise awareness of CAM.